
Journal Menu
► ▼ Journal Menu-
- Current Oncology Home
- Aims & Scope
- Editorial Board
- Reviewer Board
- Topical Advisory Panel
- Instructions for Authors
- Special Issues
- Topics
- Sections & Collections
- Article Processing Charge
- Indexing & Archiving
- Editor’s Choice Articles
- Most Cited & Viewed
- Journal Statistics
- Journal History
- Journal Awards
- Society Collaborations
- Conferences
- Editorial Office
Journal Browser
► ▼ Journal Browser-
arrow_forward_ios
Forthcoming issue
arrow_forward_ios Current issue - Volumes not published by MDPI
Need Help?
Announcements
1 October 2025
2024 MDPI Top 1000 Reviewers

We are honored to recognize the 2024 MDPI Top 1000 Reviewers—scholars whose exemplary commitment to rigorous and constructive peer review is vital in upholding the highest standards of academic publishing.
Selected from a distinguished pool of 215,000 reviewers from 65 countries and regions worldwide, these honorees stand out for their exceptional expertise, diligence, and dedication to advancing research through timely and thoughtful reviews. Their constructive and impartial feedback ensures the publication of high-quality, impactful research, while their timely reviews facilitate swift revisions and faster publication of innovative work.
Peer review is the invisible foundation of academic progress. With gratitude and respect, we celebrate these 1000 scholars who made that foundation stronger in 2024. We respected all privacy preferences, with part of nominees opting for limited attribution.
The names of these reviewers are listed below in alphabetical order by first name:
Abbas Yazdinejad |
Hany H. Arab |
Oscar De Lucio |
Abdessamad Belhaj |
Hao Zang |
Otilia Manta |
Abdolreza Jamilian |
Hatem Amin |
Panagiotis D. Michailidis |
Abdul Waheed |
Henry Alba |
Panagiotis Simitzis |
Abiel Aguilar-González |
Hiroyuki Noda |
Paola Prete |
Adina Santana |
Hitoshi Tanaka |
Paolo Trucillo |
Aditya Velidandi |
Horst Lenske |
Patricia Kara De Maeijer |
Adrian Stancu |
Hossein Azadi |
Patrícia Pires |
Adriana Borodzhieva |
Houlin Yu |
Paulo Schwingel |
Adriana Cristina Urcan |
Huaifu Deng |
Pavel Loskot |
Adriano Bressane |
Huamin Jie |
Pedro García-Ramírez |
Agbotiname Imoize |
Hugo Lisboa |
Pedro Pablo Zamora |
Agustin L. Herrera-May |
Igor L. Zakharov |
Pedro Pereira |
Ahmed Arafa |
Igor Litvinchev |
Pei-Hsun Wang |
Ahmet Cagdas Seckin |
Igor Vujović |
Pellegrino La Manna |
Ailton Cesar Lemes |
Ildiko Horvath |
Petar Ozretić |
Akash Kumar |
Ilya A. Khodov |
Petko Petkov |
Akihiko Murayama |
Ilya Zavidovskiy |
Petr Komínek |
Alain E. Le Faou |
Imran Ali Lakhiar |
Petras Prakas |
Alain Massart |
Ines Aguinaga-Ontoso |
Petro Pukach |
Alejandro Plascencia |
Ioan Hutu |
Petru Alexandru Vlaicu |
Aleksandar Ašonja |
Ioan Petean |
Phil Chilibeck |
Aleksandra Głowacka |
Irena M. Ilic |
Pia Lopez-Jornet |
Aleksandra Nesić |
Isaac Lifshitz |
Pietro Geri |
Alessio Ardizzone |
Ismael Cristofer Baierle |
Pingfan Hu |
Alessio Faccia |
I-Ta Lee |
Piotr Cyklis |
Alexander E. Berezin |
Itzhak Aviv |
Piotr Gauden |
Alexander Lykov |
Iustinian Bejan |
Piotr Gawda |
Alexander Robitzsch |
Ivan Matveev |
Pradeep Kumar Panda |
Alexandre Landry |
Ivan Pavlenko |
Pradeep Varadwaj |
Alexey Chubarov |
Ivana Mitrović |
Presentación Caballero |
Alexey Morgounov |
Iyyakkannu Sivanesan |
Pu Xie |
Alexis Rodríguez |
Jacek Abramczyk |
Qingchao Li |
Alfredo Silveira De Borba |
Jacques Cabaret |
Qinghua Qiu |
Ali Hashemizdeh |
Jaime A. Mella-Raipán |
Qingwei Chen |
Alison De Oliveira Moraes |
Jaime Taha-Tijerina |
Radoslaw Jasinski |
Aliyu Aliyu |
James Chun Lam Chow |
Radu Racovita |
Alok Dhaundiyal |
James Chung-Wai Cheung |
Rafael Galvão De Almeida |
Álvaro Antón-Sancho |
James O. Finckenauer |
Rafael Melo |
Amit Ranjan |
Jan Cieśliński |
Rafal Kukawka |
Amritlal Mandal |
Ján Moravec |
Rafał Watrowski |
Ana Isabel Roca-Fernández |
Jarbas Miguel |
Raffaele Pellegrino |
Ana Tomić |
Jaroslav Dvorak |
Rajender Boddula |
Anas Alsobeh |
Jarosław Przybył |
Ralf Hofmann |
Anastasios Karayiannakis |
Jasenka Gajdoš Kljusurić |
Ran Wang |
Andre Luiz Costa |
Jasmina Lukinac |
Ranko S. Romanić |
Andrea Bianconi |
Jawad Tanveer |
Ratna Kishore Velamati |
Andrea Sonaglioni |
Jean Carlos Bettoni |
Rebecca Creamer |
Andrea Tomassi |
Jennie Golding |
Reggie Surya |
Andrés Fernando Barajas Solano |
Jerzy Chudek |
Rehan Siddiqui |
Andrés Novoa |
Jhih-Rong Liao |
Renato Maaliw |
Andreu Comas-Garcia |
Jiachen Li |
Reuven Yosef |
Andrew Lane |
Jianzhu Liu |
Ricardo García-León |
Andrew Lothian |
Jiaquan Yu |
Richard Murray |
Andrew Sortwell |
Jibing Chen |
Robert Boyd |
Andrius Katkevičius |
Jie Gao |
Robert H. Eibl |
Andromachi Nanou |
Jie Hua |
Robert James Crammond |
Andrzej Kielian |
Jill Channing |
Robert Oleniacz |
Andrzej Kozłowski |
Jinfeng Li |
Roberto Passera |
Andrzej Zolnowski |
Jinle Xiang |
Rodolpho Fernando Vaz |
Ángel Josabad Alonso-Castro |
Jinliu Chen |
Rodrigo Galo |
Ángel Llamas |
Jinyao Lin |
Roger E. Thomas |
Angelo Ferlazzo |
Jinyu Hu |
Roger W. Bachmann |
Angelo Marcelo Tusset |
Jiří Remr |
Rogério Leone Buchaim |
Anil K. Meher |
Jiying Liu |
Roman Trach |
Animesh Kumar Basak |
João Everthon Da Silva Ribeiro |
Roman Trochimczuk |
Anita Silvana Ilak Peršurić |
Joao Pessoa |
Romil Parikh |
Anna Kharkova |
Joaquim Carreras |
Romina Fucà |
Anna Lenart-Boroń |
John Adams Sebastian |
Ronald Nelson |
Anna Piotrowska |
John Van Boxel |
Rosie Yagmur Yegin |
Anne Anderson |
Jonathan Puente-Rivera |
Roxana Lucaciu |
Antiopi-Malvina Stamatellou |
Jordi-Roger Riba |
Rui Sales Júnior |
Antonia Kondou |
Jorge De Andres-Sanchez |
Rui Vitorino |
Antonio Miguel Ruiz Armenteros |
Jorge Guillermo Diaz Rodriguez |
Ruo Wang |
Anusorn Cherdthong |
Jorge Luis Zambrano-Martinez |
Ryoma Michishita |
Aram Cornaggia |
José F. Fontanari |
Sabina Necula |
Ariana Saraiva |
José Felipe Orzuna-Orzuna |
Sabina Umirzakova |
Ariel Soares Teles |
José Francisco Segura Plaza |
Said EL-Ashker |
Aristeidis Karras |
José Luis Díaz |
Saïf Ed-Dı̂n Fertahi |
Arnaud Dragicevic |
José Luis Rivera-Armenta |
Salvatore Romano |
Artem Obukhov |
Jose M. Miranda |
Sándor Beszédes |
Arvind Kumar Shukla |
Jose M. Mulet |
Santiago Lain |
Arvind Negi |
Jose Navarro-Pedreño |
Sara Black Brown |
Athanasios A. Panagiotopoulos |
José Pedro Cerdeira |
Sarat Chandra Mohapatra |
Augustine Edegbene |
Jouni Räisänen |
Sarunas Grigaliunas |
Aunchalee Aussanasuwannakul |
Jui-Yang Lai |
Saša Milojević |
Aurel Maxim |
Juliana Fernandes |
Sawsan A. Zaitone |
Barbara Symanowicz |
Julio Plaza Díaz |
Scott E. Hendrix |
Bartosz Płachno |
Juliusz Huber |
Seong-Gon Kim |
Bela Kocsis |
Jun Liu |
Sergii Babichev |
Benedetto Schiavo |
Junyu Chen |
Sergio Da Silva |
Bernhard Koelmel |
Karan Nayak |
Sérgio Felipe |
Bhupendra Prajapati |
Karel Allegaert |
Sergio Guzmán-Pino |
Bierng-Chearl Ahn |
Katarina Aškerc Zadravec |
Seyed Kourosh Mahjour |
Bo Zhou |
Katarzyna Kubiak-Wójcicka |
Seyed Masoud Parsa |
Bohong Zhang |
Katarzyna Peta |
Shedrach Benjamin Pewan |
Bonface Ombasa Manono |
Katarzyna Tandecka |
Shehwaz Anwar |
Bozhidar Stefanov |
Katherine Bussey |
Shengwen Tang |
Brach Poston |
Katsuya Ichinose |
Shih-Lin Lin |
Byeong Yong Kong |
Kazuharu Bamba |
Shilong Li |
Caio Sampaio |
Kazuhiko Kotani |
Shing-Hwa Liu |
Caius Panoiu |
Kazuhiko Nakadate |
Shu Yuan |
Caiyun Wang |
Keigi Fujiwara |
Shuohong Wang |
Calin Mircea Gherman |
Keith Rochfort |
Shuolin Xiao |
Camelia Delcea |
Kenneth Waters |
Shuping Wu |
Cardellicchio Angelo |
Keren Dopelt |
Sihui Dong |
Carlos Alberto Ligarda Samanez |
Kira E. Vostrikova |
Sławomir Rabczak |
Carlos Almeida |
Kit Leong Cheong |
Sojung Kim |
Carlos Balsas |
Konstantinos Vergos |
Songli Zhu |
Carlos López-de-Celis |
Koyeli Girigoswami |
Soonhee Hwang |
Carlos Marcuello |
Krzysztof R. Karsznia |
Soo-Whang Baek |
Carlos Pascual-Morena |
Krzysztof Szwajka |
Soufiane Haddout |
Carlos Torres-Torres |
Krzysztof Wołk |
Sousana Papadopoulou |
Casey Watters |
Kumar Ganesan |
Spiros Paramithiotis |
Castillo Castillo |
Lan Lin |
Spyridon Kaltsas |
Changmin Shi |
László Radócz |
Srecko Stopic |
Chao Chen |
Laurent Donzé |
Srinivasan Sathiyaraj |
Chao Gu |
Lei He |
Stefano Mancin |
Chao Zhang (China) |
Lei Huang |
Subhadeep Das |
Chao Zhang (Singapore) |
Leonard-Ionut Atanase |
Sumedha Nitin Prabhu |
Chellapandian Maheswaran |
Leonardo Henrique Dalcheco Messias |
Sushant K. Rawal |
Cheonshik Kim |
Leonie Brummer |
Svetoslav Todorov |
Chia Hung Kao |
Levon Gevorkov |
Szymon Janczar |
Chiachung Chen |
Li Fu |
Tadeusz Kowalski |
Chiara Cinquini |
Lidija Hauptman |
Tadeusz Sierotowicz |
Chieh-Chih Tsai |
Lin-Fu Liang |
Taha Koray Sahin |
Christian Rojas |
Ling Yang |
Tahir Cetin Akinci |
Chu Zhang |
Lingli Deng |
Takuo Sakon |
Chuanyu Sun |
Ljubica Kazi |
Tamara Lazarević-Pašti |
Chun-Wei Yang |
Lotfi Boudjema |
Tao Zhang |
Claudia Bita-Nicolae |
Louis Moustakas |
Taras P. Pasternak |
Constant Mews |
Luca Ulrich |
Tarek Eldomiaty |
Cristian Vacacela Gomez |
Luis Adrian De Jesús-González |
Taro Urase |
Cristiano Matos |
Luis Alfonso Díaz-Secades |
Tenzer Robert |
Cristian-Valeriu Stanciu |
Luis Filipe Almeida Bernardo |
Thawatchai Phaechamud |
Cristóbal Macías Villalobos |
Luis Nestor Apaza Ticona |
Thomas Michael |
Dalia Calneryte |
Luis Puente-Díaz |
Tiberiu Harko |
Daniel Hernandez-Patlan |
Luiz Antonio Alcântara Pereira |
Timea Claudia Ghitea |
Daniele Ritelli |
Łukasz Rakoczy |
Timothy John Mahony |
Daniel-Ioan Curiac |
Łukasz Szeleszczuk |
Timothy Omara |
Daniil Olennikov |
Maciej Kruszyna |
Tomasz Hikawczuk |
Daodao Hu |
Magdalena Jaciow |
Tomasz M. Karpiński |
Daqin Guan |
Maha Nasr |
Tomasz Trzepiecinski |
Daria Chudakova |
Maharshi Bhaswant |
Triantafyllos Didangelos |
Daria Mottareale-Calvanese |
Maksim Zavalishin |
Tsvetelin Zaevski |
Dariusz Dziki |
Małgorzata Jeleń |
Ulrich J. Pont |
Dariusz Gozdowski |
Man Fai Leung |
Vadim Kramar |
David Kieda |
Manickam Minakshi |
Vagner Lunge |
David Luviano-Cruz |
Manickam Minakshi |
Valério Monteiro-Neto |
Da-Zhi Sun |
Marcel Sari |
Van Giap Do |
Debra Wetcher-Hendricks |
Marcello Iasiello |
Van-An Duong |
Demin Cai |
Marco Limongiello |
Vanni Nicoletti |
Dennis Dieks |
Marco Zucca |
Vasilios Liordos |
Deokho Lee |
Marconi Batista Teixeira |
Vedran Mrzljak |
Deyu Li |
Marcos Vinícius Da Silva |
Vicente Romo Pérez |
Diego Romano Perinelli |
Marek Cała |
Victor-Alexandru Briciu |
Dimitris Tatsis |
Maria G. Ioannides |
Viktor V. Brygadyrenko |
Dirceu Ramos |
Maria João Lima |
Vinícius Silva Belo |
Dmitrii Pankin |
Maria Kantzanou |
Violeta Popovici |
Dmitriy Yambulatov |
Maria Leonor Abrantes Pires |
Viorel Dragos Radu |
Dmitry Kultin |
Mariana Buranelo Egea |
Viswas Raja Solomon |
Dongwei Di |
Mariana Magalhães |
Viviani Oliveira |
Dorota Formanowicz |
Marija Strojnik |
Vlad Rotaru |
Dragan Marinkovic |
Marijn Speeckaert |
Vladica Stojanović |
Drazenko Glavic |
Marina G. Holyavka |
Volodymyr Hrytsyk |
Duguleana Mihai |
Marina Gravit |
Volodymyr Ponomaryov |
Dušan S. Dimić |
Mario Cerezo Pizarro |
Waldemar Studziński |
E Terasa Chen |
Mario Ganau |
Wanming Lin |
Edoardo Bucchignani |
Mariusz Ptak |
Waseem Jerjes |
Eduard Zadobrischi |
Marlen Vitales-Noyola |
Wei-Chieh Lee |
Edwin Villagran |
Marta Forte |
Weiming Fang |
Eitan Simon |
Martha Rocío Moreno-Jimenez |
Weiren Luo |
Elena Chitoran |
Marwan El Ghoch |
Weiwei Jiang |
Elena Marrocchino |
Marzena Włodarczyk-Stasiak |
Wenan Yuan |
Elisabeta Negrău |
Massimiliano Schiavo |
Wenguang Yang |
Elisavet Bouloumpasi |
Massoomeh Hedayati Marzbali |
Wenluan Zhang |
Elochukwu Ukwandu |
Mateusz Rozmiarek |
Wiesław Przygoda |
Emil Smyk |
Matt Smith |
Wilian Paul Arévalo Cordero |
Emilio Bucio |
Matteo Riccò |
Wilian Pech-Rodríguez |
Emmanouil Karampinis |
Matthias Müller |
Wislei R. Osório |
Ericsson D. Coy-Barrera |
Mauro Lombardo |
Wi-Young So |
Eugeniusz Koda |
Md. Ataur Rahman |
Wojciech Sałabun |
Ewa Chomać-Pierzecka |
Md. Biddut Hossain |
Wojciech Zabierowski |
Ewa Tomaszewska |
Meisam Abdollahi |
Xiaofei Du |
Ezhaveni Sathiyamoorthi |
Meng-Hwan Lee |
Xiaolong Ji |
Fabio Corti |
Meng-Yao Li |
Xiaomin Xu |
Fahmi Zairi |
Meysam Keshavarz |
Xiaoshuang Ma |
Fanzhi Kong |
Michael Eisenhut |
Xiaoying Liu |
Fasih Ullah Haider |
Michael Gerlich |
Xiao-Yong Wang |
Fayez Tarsha-Kurdi |
Mihaela Brindusa Tudose |
Xinming Zhang |
Fekete Mónika |
Mihaela Niculae |
Xinqiao Liu |
Felipe Jiménez |
Mihaela Tinca Udristioiu |
Xinqing Xiao |
Feng Wen |
Mihaela Toderaş |
Xuechen Zheng |
Ferdinando Di Martino |
Mihai Crenganis |
Xueming Zhang |
Fernanda Tonelli |
Mika Simonen |
Xuezhen Wang |
Fernando Lessa Tofoli |
Milan Toma |
Xuguang Cai |
Fernando Viadero-Monasterio |
Miloš Lichner |
Yair Wiseman |
Fethi Ouallouche |
Milos Seda |
Yang Xu |
Flavio Arroyo |
MIloš Zrnić |
Yangwon Lee |
Flor H. Pujol |
Min Xia |
Yanhong Peng |
Florin Dumitru Bora |
Mina Tadros |
Yao Ni |
Florin Nechita |
Mingren Shen |
Yaoxiang Li |
Francesco Di Bello |
Mircea Neagoe |
Yasushige Shingu |
Francesco Galluzzo |
Mirela-Fernanda Zaltariov |
Yaswanth Kuthati |
Francisco Haces Fernandez |
Mirjana Ljubojević |
Yaxin Liu |
Francisco Rego |
Mirko Stanimirović |
Ygor Jessé Ramos |
Francisco Solano |
Mirza Pojskić |
Yi Xu |
Frédéric Muttin |
Modesto Pérez-Sánchez |
Yifan Zhao |
Fredrick Eze |
Mohammad Ali Sahraei |
Yih Jeng |
Gabriel Milan |
Mohammad Javad Maghsoodi Tilaki |
Yiyang Chen |
Gabriel Zazeri |
Mohammad Qneibi |
Yoichi Shiraishi |
Galina Ilieva |
Mohammed Gamal |
Yong Hwan Kim |
Gary Van Vuuren |
Mohammed Sayed |
Yongqi Yin |
Gennadiy Kolesnikov |
Mounia Tahri |
Young-joo Ahn |
George E. Mustoe |
Muhammad Ahsan Asghar |
Yousi Fu |
George Lazaroiu |
Muhammad N. Mahmood |
Yuan Meng |
George Xiroudakis |
Muhammad Syafrudin |
Yuefei Zhuo |
Georgiy Gamov |
Muhammed Yildirim |
Yugang He |
Gerald Cleaver |
Murilo E. C. Bento |
Yuliia Trach |
Ghassan Ghssein |
Muthuraj Arunpandian |
Yuliya Semenova |
Gian Mario Migliaccio |
Narcis Eduard Mitu |
Yuri Jorge Peña-Ramirez |
Giancarlo Trimarchi |
Naser Alsharairi |
Yuri Konstantinov |
Gianmarco Ferrara |
Natale Calomino |
Yusheng Xiang |
Giovanni Tesoriere |
Natanael Karjanto |
Yutaka Ohsedo |
Giuseppe Brunetti |
Nataša Nastić |
Zaihua Duan |
Giuseppe Di Martino |
Naveed Ahmad |
Zelaya-Molina Lily Xochilt |
Giuseppe Losurdo |
Nebojsa Pavlovic |
Zenon Pogorelić |
Giuseppina Uva |
Neli Milenova Vilhelmova |
Zhang Ying |
Glauber Cruz |
Nguyen Dinh-Hung |
Zhanni Luo |
Glenn Morrison |
Nguyen Quoc Khuong |
Zhao Ding |
Gloria Cerasela Crisan |
Nicola Magnavita |
Zhengmao Li |
Gordana Wozniak-Knopp |
Nicoleta Dospinescu |
Zhengwei Huang |
Gordon Alderink |
Nicoletta Cera |
Zhidong Zhou |
Grazia Giuseppina Politano |
Nidhi Puranik |
Zhijun Li |
Grigorios L. Kyriakopoulos |
Nikita Osintsev |
Zhixiong Lu |
Grzegorz Woroniak |
Nikita V. Martyushev |
Zhizhong Zhang |
Grzegorz Zieliński |
Nikola Stanisic |
Zhong-Gao Jiao |
Guadalupe Gabriel Flores-Rojas |
Nilakshi Barua |
Zia Muhammad |
Guanxi Yan |
Nobuo Funabiki |
Žiga Laznik |
Guoyou Zhang |
Octavian Vasiliu |
Zigmantas Gudžinskas |
Gustavo Henrique Nalon |
Oguzhan Der |
Zishan Ahmad |
Hai-Yu Ji |
Oimahmad Rahmonov |
Zivan Gojkovic |
Hamza Faraji |
Olga Morozova |
Zoran Mijić |
Hamza Sohail |
Onur Dogan |
Zsuzsanna Bacsi |
Hanane Boutaj |
Ophir Freund |
2 October 2025
MDPI INSIGHTS: The CEO's Letter #27 - OASPA 2025, COUNTER 5.1, UK Summit in London, MDPI at the Italian Senate

Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
MDPI at OASPA 2025: Embracing the Complexity of Open Access
From 22 to 24 September, I joined the OASPA 2025 Annual Conference in Leuven, Belgium, where the theme, “Embracing the Complexity – How do we get to 100% Open Access?” tackled the hard questions about the future of scholarly communication.
With MDPI a longstanding member of the Open Access Scholarly Publishing Association (OASPA) and Platinum sponsor of the conference, I was invited to present and participate in important discussions on how we can continue to move the needle in Open Access (OA) publishing.
From 50% to 100% Open Access
Last year’s OASPA conference celebrated a major milestone – reaching 50% of global research outputs published as OA. But, as noted during the conference, this was the “easy” part. The challenge ahead is much tougher: how do we take OA from 50% to 100%? For many academics and institutions, OA is still relatively new, and thus it is essential for us to continue educating people as to what OA is, how it works, and why it matters.
Stefan Tochev (CEO, MDPI) presenting at OASPA’s 2025 Annual Conference in Leuven, Belgium.
MDPI’s perspective
At MDPI, we are fully committed to this. As a 100% OA publisher, our growth is inseparable from the success of OA itself. In many ways, MDPI is a byproduct of the global adoption of OA, and we play an important role in helping to advance it further.
I had the opportunity to share MDPI’s perspective in the panel discussion entitled: "Hello from the other side: views from fully Open Access journals using APCs," alongside industry colleagues from PLOS, eLife, AOSIS, and Frontiers.
Instead of giving a standard presentation, I highlighted aspects of MDPI that the audience might not be aware of. I also presented on the opportunities and challenges facing publishers that are already fully OA, the importance of diverse models in achieving 100% OA, and why OA is the baseline while Open Science is the future.
Recognizing Gold OA
As part of the panel, I had undertaken to make some bold and provocative statements. I therefore emphasized a point that is sometimes overlooked: we didn’t reach 50% OA without Gold OA – it accounts for more than half of all OA publications today. And we certainly won’t reach 100% OA without it.
“By educating the community and working together, we can continue to take Open Science to the next level”
“When people speak about Gold OA and MDPI, they should ‘put some respek on our name.”
MDPI is a leader in Gold OA and has been a driver of this progress at scale.
While Gold OA and MDPI are sometimes slighted, both deserve recognition for their contributions to advancing Open Science globally.
I closed my presentation with a reminder that the good we do is sometimes overlooked, and that when people speak about Gold OA and MDPI, they should "put some respek on our name."
I’m pleased to have seen attendees sharing positive experiences with MDPI, reminding us that we bring real value to the OA movement and deserve a stronger reputation. We also engaged in constructive conversations about various topics, including cost transparency.
A few themes that I took away from the conference:
- Quality and integrity matter as much as access. OA publishers must not lose sight of research integrity, inclusivity, and sustainability while pursuing 100% OA.
- Global collaboration is essential. Policies, funding models, and infrastructure differ around the world, and we will need cross-border collaboration to make OA a truly global reality.
- Open Science is the bigger story. OA is just the first step – the future lies in open data, open peer review, research reproducibility, etc.
“MDPI’s scale allows us to better support authors, reinvest in communities, and push Open Science forward”
How we communicate MDPI’s role
For us at MDPI, this is also a reminder of how we communicate externally. When we tell our story, we shouldn’t forget to start with the bigger picture – Open Science and Open Access. Then we connect it to MDPI, our journals, services, and initiatives, exemplifying the fact that we are part of a mission larger than ourselves.
MDPI colleagues Clàudia Aunós (Society Partnerships), Marta Colomer (External Affairs), Stefan Tochev (CEO), and Nikola Paunovic (Scilit), at OASPA’s 2025 Annual Conference in Leuven, Belgium.
The journey to 100% OA will not be simple. But by educating the community and working together, we can continue to take Open Science to the next level.
Impactful Research
MDPI becomes COUNTER 5.1 compliant across 480+ Journals
I’m pleased to share that MDPI has officially become COUNTER 5.1 compliant and has joined the COUNTER Registry.
For those who might not be familiar with it, COUNTER provides international standards for tracking and reporting how research is being used. By becoming COUNTER 5.1 compliant, MDPI can now deliver credible, comparable, and transparent usage reports across our entire journal portfolio.
“MDPI is showing that they want to be measured against the same yardstick as other publishers”
Why is this important?
Because usage statistics aren’t just numbers: they’re powerful tools that help our authors, institutions, and consortia understand the real impact of their research. With COUNTER compliant reports, our institutional partners can now make more informed decisions about publishing agreements, funding allocations, and the long-term value of Open Access.
In practical terms, MDPI will now provide Platform, Title, and Item Reports, with standardized usage views available at the institute and consortium level. These reports cover usage from January 2024 onwards and will be updated monthly. Institutions will be able to access them via SuSy, or automatically through the COUNTER API.
I’d like to highlight and thank Becky Castellon, our Institutional Partnerships Manager, who has played a key role in driving this project forward. Becky captured it perfectly when she said: "Through these usage reports, our global research community can access trustworthy data about how their work is being used and accessed
This information is often vital for reviewing publishing partnership agreements and for making informed decisions about future funding allocations."
We also received encouraging feedback from Tasha Mellins-Cohen, Executive Director at COUNTER Metrics:
"We’re delighted to see born-OA publishers engaging with COUNTER. Our normalised usage metrics are relied on as the basis for credible return-on-investment calculations by libraries worldwide. By adopting the COUNTER standard, MDPI is showing that they want to be measured against the same yardstick as other publishers."
For MDPI, this milestone is another step in our commitment to transparency, trust, and impact. By adopting COUNTER’s standards, we’re not just aligning with best practice; we’re ensuring that Open Access publishing is measured on the same terms as traditional publishing, proving its value in concrete and globally recognized ways.
This is an important milestone for MDPI, but more importantly for the researchers, librarians, and institutions we serve. Transparency builds trust, and COUNTER compliance helps us show the global reach and influence of Open Access publishing in the clearest way possible.
Inside Research
Lin Li (Publisher, MDPI), Stefan Tochev (CEO, MDPI, Prof. Chengkuo Lee (Editor-in-Chief, AI Sensors), and Constanze Schelhorn (Head of Indexing) at restaurant in Basel, Switzerland.
Welcoming Prof. Lee (EiC of AI Sensors) to Basel
On 11 September, we welcomed Prof. Dr. Chengkuo Lee, Editor-in-Chief of our new journal AI Sensors, to our Basel office. Prof. Lee is a high profiled researcher (h-index 104, 37,000+ citations), a longtime collaborator with MDPI (25 published articles), and has already chaired several AI Sensors (AIS)-related conferences with us, including the recent event in Kuala Lumpur, where AI Sensors held its first editorial board meeting.
Stefan Tochev (CEO, MDPI) showing Special Issue reprint books as part of a tour of MDPI’s Basel office.
Every journal has a story
During his visit, we exchanged ideas on how to build the journal’s identity and impact. A key takeaway that I shared was that every journal has a story: its vision, its purpose, and the community it brings together.
That story is what connects with readers and authors, beyond metrics alone.
I encouraged everyone working on journals to reflect: What is the story of your journal? And how can you bring that story to the forefront in how you communicate about it?
How MDPI supports new journals
Constanze Schelhorn (Head of Indexing, MDPI) presenting on the MDPI indexing process at the company’s headquarters in Basel.
We also shared with Prof. Lee how MDPI supports journals through our Institutional Open Access Program, indexing expertise, and the work of our Journal Relationship Specialists.
Launching a new journal is ambitious, but with our strong track record (93% Scopus and 87% Web of Science acceptance rates in 2024), Prof. Lee felt confident that AI Sensors will find its place in the scholarly landscape.
Having spent some hours together, it’s clear that Prof. Lee is not only an Editor-in-Chief but also an ambassador for MDPI. His leadership and collaboration reflect the mission MDPI by which MDPI lives: accelerating Open Access and advancing Open Science.
Special thanks to Constanze Schelhorn (Head of Indexing), Ting Leng (JRS, Managing Editor, AI Sensors), Lin Li (Publisher, AI Sensors), Aimar Xiong (Publisher), and Christian Eberhard (Office Administrator, Basel), for organizing and hosting the meeting.
Coming Together for Science
Highlights from the MDPI UK Summit in London
I was pleased to be back in the UK in September, supporting our Manchester team in hosting their first MDPI Summit in London. This day-and-a-half private event brought together 25 Chief Editors and Associate Editors to exchange knowledge, learn about latest developments at MDPI, and engage in discussions on advancing Open Science. The program included MDPI and guest presentations, and Q&A sessions.
Why these summits matter
Our Summits provide a platform to:
- Share updates on the latest developments at MDPI, our editorial processes, research integrity practices, and indexing.
- Highlight collaborations with institutions and societies in the region.
- Offer external perspectives from guest speakers.
- Create space for Chief Editors to share their insights, ask questions, network, and help shape MDPI’s path forward.
These gatherings are more than updates: they improve our relationships with Chief Editors, who serve not only as leaders of their journals but also as ambassadors for MDPI within the research community. We often hear that this type of event is unique, something many other publishers do not provide. It shows that we care and are willing to go the extra mile to recognize and engage our key collaborators.
|
|
|
MDPI and the UK: Key facts
- With over 80,000 publications, the UK is MDPI’s eighth-largest contributor.
- MDPI is the fourth-largest publisher in the UK, accounting for 11% of the country’s 89,526 Open Access publications in 2024.
- We collaborate with more than 4,000 active UK Editorial Board Members, 48% of whom have an H-index above 26. This includes 49 Editors-in-Chief and 74 Section Editors-in-Chief.
- MDPI maintains over 1,000 IOAP agreements worldwide, with 63 from the UK.
“We are willing to go the extra mile to recognize and engage our key collaborators”
|
|
|
|
|
|
Agenda highlights:
- MDPI Overview, Open Access, and UK Collaboration – Stefan Tochev (CEO, MDPI)
- MDPI Editorial Process – Dr. Michael O’Sullivan (Scientific Quality Advisor Lead, MDPI)
- Research Integrity and Publication Ethics – Daisy Fenton (Research Integrity Specialist, MDPI)
- Institutional Partnerships – Becky Castellon (Institutional Partnerships Manager, MDPI)
- Promoting and Developing Your Journal – Prof. Fabio Tosti (Editor-in-Chief of NDT)
- Indexing to Impact – Dr. Michael O’Sullivan (Scientific Quality Advisor Lead, MDPI)
- Engaging our Academic Community – Jaime Anderson Anderson (UK Operations Manager, MDPI)
- Closing Remarks – Stefan Tochev (CEO, MDPI)
MDPI colleagues Stefan Tochev (CEO), Jaime Anderson Anderson (UK Operations Manager), Dr. Michael O’Sullivan (Scientific Quality Advisor Lead), Becky Castellon (Institutional Partnerships Manager), Daisy Fenton (Research Integrity Specialist) at the MDPI UK 2025 Summit in London.
Thank you!
A special thank-you to the Manchester team and all colleagues behind the scenes who made this Summit a success. Your efforts are greatly appreciated. We look forward to building on this momentum with future Summits in Europe and beyond.
Closing Thoughts
Dr. Giulia Stefenelli (Scientific Communications Lead, MDPI) and Stefan Tochev (CEO, MDPI) participating in a press conference at the Italiane Senate in Rome to promote the 2nd International Conference on Environmental Medicine (ICEM)
MDPI at the Italian Senate: Promoting Environmental Medicine and Open Science
On 16 September, Dr. Giulia Stefenelli (Scientific Communications Lead) and I had the honour of participating in a press conference at the Italian Senate in Rome, organized by the Italian Society of Environmental Medicine (SIMA) to promote the upcoming 2nd International Conference on Environmental Medicine (ICEM) (20–21 November 2025).
This is an important event for MDPI, as we are the exclusive publishing partner for ICEM and have recently launched a new journal with SIMA, further building our presence both in Italy and within this important field of research.
Why this matters
- The promotion of ICEM has received extensive national media coverage (more than 15 mentions in major Italian outlets; see links below).
- The press conference brought together leading policymakers, academics, and Nobel Laureates to emphasize the impact of environmental exposures and epigenetics on human health.
- We were introduced to government ministries, university rectors, and influential stakeholders, which helps us bolster MDPI’s visibility and reputation in Italy.
Highlights
Nobel Laureate Sir Richard Roberts joined the discussion, underlining the importance of environmental medicine in shaping future health outcomes. Nobel Laureate Prof. Dr. Tong Zhu (Peking University) will also speak at the November conference.
Institutional representatives included the Italian Minister of the Environment and Energy Security, the Italian Undersecretary for Health, and senior officials from the World Health Organization.
In my closing remarks, I highlighted that:
“Over the past five years, about 65% of research published in Italy has been Open Access, compared to an average of 55% worldwide.”
Italian research ranked seventh among the top 20 countries in average citations during this period, reflecting its strong international influence. Not only is Italy producing a high volume of research; it is also producing research of outstanding quality.
MDPI’s role
This event was not only about promoting ICEM but also about showcasing MDPI’s commitment to Open Access and our ability to connect scientific publishing with leading academic, medical, and policy institutions.
As Giulia Stefenelli noted:
“This event was highly relevant for MDPI, as it not only showcased our strong commitment to OA but also emphasized our role in advancing important fields such as Environmental Medicine.”
Learn more
- Watch the full press conference (Radio Radicale)
- Giulia’s speech: 33:20 (in Italian)
- Stefan’s speech: 57:50 (in English)
- ICEM 2025 Conference Program
- Selected media coverage:
This moment at the Italian Senate shows how MDPI can connect publishing with science, policy, and society to help advance both Open Science and environmental health research on a global stage.
|
|
In Rome with Sir Richard Roberts (photo left) and Prof. Giuseppe Novelli (EiC of MDPI journal COVID).
Chief Executive Officer
MDPI AG
30 September 2025
Nobel Prize — The Science Behind the Prize

Nobel Prizes are the world’s most prestigious recognition of scientific breakthroughs, honoring discoveries that push the boundaries of knowledge and reshape entire fields. They bring into the public eye researchers whose work might otherwise remain known only within specialized circles.
For many, winning a Nobel Prize is a surreal experience. Laureates often describe a mix of joy, humility, reflection, and gratitude for the teams and collaborators whose contributions made the achievement possible. Behind every Nobel-winning idea lies years of careful, incremental work—a process that often goes unseen.
When Prof. Steven Weinberg won the Nobel Prize in Physics in October 1979, his wife Louise, a legal scholar, reminded him to keep doing the ordinary hard work of science, joking: “Now you have to write some unimportant papers.” True to form, Weinberg continued to push the boundaries of our understanding of the Universe, showing that curiosity and dedication extend far beyond the moment of recognition (Hofmann 2025: https://www.mdpi.com/2073-8994/17/6/840).
Discover the science behind the world’s most transformative ideas
Over the years, dozens of Nobel laureates have published their work with MDPI, entrusting our open access journals to disseminate their findings to a global audience. As of 2024, more than 40 laureates have contributed over 115 articles across 35 journals, ranging from pioneering research on microRNAs and mRNA therapeutics, to fundamental insights in theoretical physics, and advances in structural biology.
We regularly spotlight how Nobel Prize–winning research intersects with the contributions of our authors. This not only celebrates the achievements of the laureates, but also underscores the role of open access in ensuring that transformative science reaches the widest possible audience.
On this page, we invite you to explore selected works by Nobel laureates within the MDPI portfolio, and to join us in celebrating the global impact of their ideas.
The Nobel Prize in Physiology or Medicine 2025 will be announced on October 6 at 11:30 am CEST (at the earliest), awarded by the Nobel Assembly at Karolinska Institutet, Stockholm, Sweden. MDPI sincerely invites you to explore research in a related field.
The Science Behind the Prize: 2025 Nobel Physiology or Medicine Roundtable
6 October 2025, 03:30 pm (CEST)
Free to register for this webinar here!
The Nobel Prize in Physics 2025 will be announced on October 7 at 11:45 am CEST (at the earliest), awarded by the Royal Swedish Academy of Sciences, Stockholm, Sweden. MDPI sincerely invites you to explore research in a related field.
The Science Behind the Prize: 2025 Nobel Physics Roundtable
7 October 2025, 02:30 pm (CEST)
Free to register for this webinar here!
The Nobel Prize in Chemistry 2025 will be announced on October 8 at 11:45 am CEST (at the earliest), awarded by the Royal Swedish Academy of Sciences, Stockholm, Sweden. MDPI sincerely invites you to explore research in a related field.
27 September 2025
Welcoming New Editorial Board Members of Current Oncology

We are pleased to announce the recent appointment of five new scholars as Editorial Board Members for Current Oncology (ISSN: 1718-7729). We wish our new members success in both their research and in their efforts to develop the journal.
Name: Prof. Dr. Maciej Jóźwik
Affiliation: Department of Gynecology and Gynecologic Oncology, Medical University of Białystok, Białystok, Poland
Interests: multifactorial pathogenesis of endometrial cancer and ovarian cancer; the role of endometriosis in cancer promotion; prevention of endometrial cancer; the links of endometrial cancer with the metabolic syndrome; the role of GAPDH (glyceraldehyde-3-phosphate dehydrogenase) in malignant disease
Name: Prof. Giovanni Succo
Affiliation: Azienda Sanitaria Ospedaliera Molinette San Giovanni Battista Di Torino, Turin, Italy
Interests: head and neck oncology; laryngeal oncology; head and neck surgery; laryngeal surgery; mini-invasive head and neck surgery
Name: Prof. Dr. R. Daniel Bonfil
Affiliation: Department of Medical Education, Dr. Kiran C. Patel College of Allopathic Medicine, Nova Southeastern University, 3200 South University Drive, Fort Lauderdale, FL, 33328, USA
Interests: invasion and metastasis; angiogenesis; bone metastasis; molecular mechanisms of prostate cancer; liquid biopsies
Name: Dr. Panagiotis Vlachostergios
Affiliations: 1 Department of Medical Oncology, IASO Thessalias Hospital, Larissa, Greece;
2 Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA
Interests: identification of biomarkers for prostate; kidney and bladder cancer; neuroendocrine prostate cancer; PSMA theranostics; upper tract urothelial carcinoma; treatment-resistant urothelial carcinoma; genomics and immunogenomics for urological cancers
Name: Dr. Alejandro Martin Sanchez
Affiliation: Multidisciplinary Breast Center, Dipartimento Scienze della Salute della Donna e del Bambino e di Sanità Pubblica, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy
Interests: breast surgery; surgery; surgical oncology; breast cancer management; breast cancer screening; senology; breast imaging; mammography; breast cancer; breast cancer stem cells
Further details about the Editorial Board of Current Oncology can be found by clicking the following link: https://www.mdpi.com/journal/curroncol/editors.
Current Oncology is recruiting scholars from around the world to join our Editorial Board. To apply for membership, recommend potential candidates, or request further information, please contact the Current Oncology Editorial Office and provide the following files:
- Your full academic CV;
- A short cover letter that details your interest in the position.
Current Oncology Editorial Office
27 September 2025
Current Oncology | Highly Cited Special Issues in 2023–2024

We are pleased to invite you to read our selection of highly cited Special Issues in 2023 and 2024 in Current Oncology (ISSN: 1718-7729). We hope that they offer useful insights in this field.
Our list of highly cited Special Issues is outlined below:
“Editorial Board Members’ Collection Series: Contemporary Perioperative Concepts in Cancer Surgery”
Guest Editors: Prof. Dr. Vijaya Gottumukkala and Prof. Dr. Jörg Kleeff
Viewed by 71080+ | Cited by 130+
“Successes, Challenges, and Ways Forward in the Field of Global Oncology”
Guest Editors: Dr. Fabio Ynoe de Moraes, Dr. Myriam Mutebi and Dr. Bishal Gyawali
Viewed by 40050+ | Cited by 100+
“New Advances in the Treatment of Resectable Non-small Cell Lung Cancer”
Guest Editors: Dr. Francesco Facciolo, Dr. Luca Bertolaccini and Dr. Federico Cappuzzo
Viewed by 51500+ | Cited by 95+
“Combination Therapy in Gastrointestinal Cancers”
Guest Editor: Dr. Hiroyuki Uetake
Viewed by 51300+ | Cited by 95+
“Epidemiology and Risk Factors of Skin Cancer”
Guest Editor: Prof. Dr. Leslie K. Dennis
Viewed by 55050+ | Cited by 95+
“Adolescent and Young Adult Oncology—Ongoing Challenges and Developments in the Future”
Guest Editors: Prof. Dr. Katrin Scheinemann, Dr. Maria Otth and Prof. Dr. Uta Dirksen
Viewed by 42550+ | Cited by 75+
“Treatment for Glioma: Retrospect and Prospect”
Guest Editors: Prof. Andrea Landi, Dr. Valentina Baro and Prof. Dr. Giuseppe Lombardi
Viewed by 33440+ | Cited by 75+
“Breast Cancer: A Multi-Disciplinary Approach from Imaging to Therapy”
Guest Editor: Dr. Daniele Ugo Tari
Viewed by 40550+ | Cited by 70+
11 September 2025
Meet Us at the 38th Annual Congress of the European Association of Nuclear Medicine, 4–8 October 2025, Barcelona, Spain

Conference: 38th Annual Congress of the European Association of Nuclear Medicine
Date: 4–8 October 2025
Location: Barcelona, Spain
We are pleased to announce that MDPI will participate in the 38th Annual Congress of the European Association of Nuclear Medicine (EANM25), to be held in Barcelona, Spain, from 4 to 8 October 2025.
One of the highlights of this year’s congress will be the continued focus on novel advances in theranostics. This rapidly evolving field continues to revolutionize our approach to diagnosis and treatment, offering unprecedented precision and personalized care for our patients. We have an exciting program lined up, featuring leading experts who will share their insights and latest research findings.
MDPI is excited to participate in this prestigious event! Representing the journal Diagnostics (ISSN: 2075-4418), Ms. Florina Maria Muresan and Ms. Lassie Shu will be present at the MDPI exhibition stand, where they will warmly welcome all scholars to stop by and engage in insightful discussions. This event presents a unique opportunity for participants to interact with leading experts in the field and explore potential collaborations. Do not miss the chance to visit our stand and exchange ideas with the MDPI editors and other delegates!
The following MDPI journals will be represented at the conference:
- Diagnostics;
- Diseases;
- Cancers;
- JCM;
- JPM;
- Medical Sciences;
- Tomography;
- Medicina;
- J. Imaging;
- Current Oncology;
- Uro.
If you are planning to attend the conference, please feel free to start a conversation with us. We invite all conference attendees to visit MDPI’s booth and meet with our esteemed Editorial Board Members.
For more information about the conference, please visit the following website: https://eanm25.eanm.org/.
9 September 2025
Current Oncology | Highly Cited Papers and Hot Topic Special Issues on Psychosocial Oncology
Psycho-oncology deals with psychological reactions to the experience of cancer, the behavioral component of coping with cancer, as well as health behavior change, including preventative medicine, and social factors that are associated with the diagnosis and treatment of cancer. We welcome you to read the following highly cited papers published in the Current Oncology (ISSN: 1718-7729) and hope that these articles can bring new ideas for psycho-oncology research. In addition, some Special Issues on this topic are currently open for submission.
1. “Psychosocial Interventions for the Treatment of Cancer-Related Fatigue: An Umbrella Review”
by Nieves Cedenilla Ramón, Jose Ignacio Calvo Arenillas, Sandra Aranda Valero, Alba Sánchez Guzmán and Pedro Moruno Miralles
Curr. Oncol. 2023, 30(3), 2954-2977; https://doi.org/10.3390/curroncol30030226
Available online: https://www.mdpi.com/1718-7729/30/3/226
2. “The Stigma Surrounding Opioid Use as a Barrier to Cancer-Pain Management: An Overview of Experiences with Fear, Shame, and Poorly Controlled Pain in the Context of Advanced Cancer”
by Hannah Harsanyi, Colleen Cuthbert and Fiona Schulte
Curr. Oncol. 2023, 30(6), 5835-5848; https://doi.org/10.3390/curroncol30060437
Available online: https://www.mdpi.com/1718-7729/30/6/437
3. “Is It Possible to Notice the Unmet Non-Medical Needs among Cancer Patients? Application of the Needs Evaluation Questionnaire in Men with Lung Cancer”
by Karolina Osowiecka, Marcin Kurowicki, Jarosław Kołb-Sielecki, Anna Gwara, Marek Szwiec, Sergiusz Nawrocki and Monika Rucinska
Curr. Oncol. 2023, 30(3), 3484-3493; https://doi.org/10.3390/curroncol30030264
Available online: https://www.mdpi.com/1718-7729/30/3/264
4. “Quality of Life in Cancer Patients: The Modern Psycho-Oncologic Approach for Romania—A Review”
by Monica Licu, Claudiu Gabriel Ionescu and Sorin Paun
Curr. Oncol. 2023, 30(7), 6964-6975; https://doi.org/10.3390/curroncol30070504
Available online: https://www.mdpi.com/1718-7729/30/7/504
5. “Psychosocial Wellbeing among Patients with Breast Cancer during COVID-19”
by Martine C. Maculaitis, Xianchen Liu, Alexandra Berk, Angelina Massa, Marisa C. Weiss, Samantha K. Kurosky, Benjamin Li and Lynn McRoy
Curr. Oncol. 2023, 30(4), 3886-3900; https://doi.org/10.3390/curroncol30040294
Available online: https://www.mdpi.com/1718-7729/30/4/294
6. “Are Canadian Women Prepared for the Transition to Primary HPV Testing in Cervical Screening? A National Survey of Knowledge, Attitudes, and Beliefs”
by Ben Haward, Ovidiu Tatar, Patricia Zhu, Gabrielle Griffin-Mathieu, Emily McBride, Jo Waller, Julia Brotherton, Aisha Lofters, Marie-Hélène Mayrand, Samara Perez et al.
Curr. Oncol. 2023, 30(7), 7055-7072; https://doi.org/10.3390/curroncol30070512
Available online: https://www.mdpi.com/1718-7729/30/7/512
7. “Beauty Therapy to Support Psychosocial Recovery from Oncological Care: A Qualitative Research on the Lived Experience of Women with Breast Cancer Treated with Chemotherapy”
by Denise Vagnini, Massimo Maria Grassi, Francesco Valenti, Emilio Bombardieri and Emanuela Saita
Curr. Oncol. 2024, 31(5), 2527-2541; https://doi.org/10.3390/curroncol31050189
Available online: https://www.mdpi.com/1718-7729/31/5/189
8. “Positive Psychological Well-Being in Early Palliative Care: A Narrative Review of the Roles of Hope, Gratitude, and Death Acceptance”
by Elena Bandieri, Eleonora Borelli, Sarah Bigi, Claudia Mucciarini, Fabio Gilioli, Umberto Ferrari, Sonia Eliardo, Mario Luppi and Leonardo Potenza
Curr. Oncol. 2024, 31(2), 672-684; https://doi.org/10.3390/curroncol31020049
Available online: https://www.mdpi.com/1718-7729/31/2/49
9. “Applying Implementation Science to Identify Primary Care Providers’ Enablers and Barriers to Using Survivorship Care Plans”
by Brittany Mutsaers, Tori Langmuir, Carrie MacDonald-Liska, Justin Presseau, Gail Larocque, Cheryl Harris, Marie-Hélène Chomienne, Lauriane Giguère, Paola Michelle Garcia Mairena, Dina Babiker et al.
Curr. Oncol. 2024, 31(6), 3278-3290; https://doi.org/10.3390/curroncol31060249
Available online: https://www.mdpi.com/1718-7729/31/6/249
10. “Two-Step Screening for Depression and Anxiety in Patients with Cancer: A Retrospective Validation Study Using Real-World Data”
by Bryan Gascon, Joel Elman, Alyssa Macedo, Yvonne Leung, Gary Rodin and Madeline Li
Curr. Oncol. 2024, 31(11), 6488-6501; https://doi.org/10.3390/curroncol31110481
Available online: https://www.mdpi.com/1718-7729/31/11/481
Special Issues:
|
|
“Psychological Interventions for Cancer Survivors” Guest Editor: Dr. Christian Schulz-Quach Submission deadline: 31 December 2025 |
“Pathways to Recovery and Resilience in Breast Cancer Survivorship” Guest Editor: Prof. Dr. Nazanin Derakhshan Submission deadline: 31 December 2025 |
|
|
“Routine Screening for Distress, Depression and Anxiety in Oncology: Where Are We Now?” Guest Editors: Dr. Daniel C. McFarland and Dr. Lee A. Kehoe Submission deadline: 31 January 2026 |
“Health Disparities and Outcomes in Cancer Survivors” Guest Editor: Dr. Claire Jungyoun Han Submission deadline: 30 April 2026 |
9 September 2025
Current Oncology | Invitation to Explore the Editor’s Choice Articles
Editor’s Choice Articles are selected based on suggestions from the Academic Editors of Current Oncology (ISSN: 1718-7729). The editors select a small number of published articles that they consider particularly interesting to our readers or important in their respective fields of research. You are therefore invited to read the Editor’s Choice Articles, a curated list of high-quality articles published in Current Oncology. The full list of Editor’s Choice Articles can be viewed via the following link: https://www.mdpi.com/journal/curroncol/editors_choice.
1. “Pediatric Brain Tumours: Lessons from the Immune Microenvironment”
by Betty Yao, Alberto Delaidelli, Hannes Vogel and Poul H. Sorensen
Curr. Oncol. 2023, 30(5), 5024-5046; https://doi.org/10.3390/curroncol30050379
2. “Next Wave of Targets in the Treatment of Advanced Renal Cell Carcinoma”
by Luisa M. Cardenas, Jasna E. Deluce, Shahrukh Khan, Omar Gulam, Saman Maleki Vareki, Ricardo Fernandes and Aly-Khan A. Lalani
Curr. Oncol. 2022, 29(8), 5426-5441; https://doi.org/10.3390/curroncol29080429
3. “Invasive Fungal Disease in Patients with Chronic Lymphocytic Leukemia in Japan: A Retrospective Database Study”
by Takeo Yasu, Kotono Sakurai and Manabu Akazawa
Curr. Oncol. 2022, 29(5), 3242-3251; https://doi.org/10.3390/curroncol29050264
4. “Cancer-Associated Fibroblasts and Extracellular Matrix: Therapeutical Strategies for Modulating the Cholangiocarcinoma Microenvironment”
by Mirko Minini and Laura Fouassier
Curr. Oncol. 2023, 30(4), 4185-4196; https://doi.org/10.3390/curroncol30040319
5. “Neurologic Complications of Cancer Immunotherapy”
by Aseel N. Alsalem, Leslie A. Scarffe, Hannah R. Briemberg, Ashley E. Aaroe and Rebecca A. Harrison
Curr. Oncol. 2023, 30(6), 5876-5897; https://doi.org/10.3390/curroncol30060440
6. “Evolution of the Surgical Management of Lung Cancer Invading the Spine: A Single Center Experience”
by Gabrielle Drevet, Théo Broussolle, Yanis Belaroussi, Lucie Duponchelle, Jean Michel Maury, Renaud Grima, Gualter Vaz, Clément Silvestre and François Tronc
Curr. Oncol. 2022, 29(5), 3061-3071; https://doi.org/10.3390/curroncol29050248
7. “X or Y Cancer: An Extensive Analysis of Sex Differences in Lung Adenocarcinoma”
by Raneem Yaseen Hammouz, Magdalena Orzechowska, Dorota Anusewicz and Andrzej K. Bednarek
Curr. Oncol. 2023, 30(2), 1395-1415; https://doi.org/10.3390/curroncol30020107
8. “Prevalence and Significance of Incidental PET/CT Findings of Cancer Detected in Patients Evaluated for Their Primary Hematologic Malignancy: A Systematic Review”
by Jessie Luo, Nizar J. Bahlis, Denise Chan, Peter Duggan, Victor H. Jimenez-Zepeda, Holly Lee, Sylvia McCulloch, Paola Neri and Jason Tay
Curr. Oncol. 2024, 31(12), 7445-7458; https://doi.org/10.3390/curroncol31120550
3 September 2025
Join Us at the MDPI at the University of Toronto Career Fair, 23 September 2025, Toronto, ON, Canada

Date: 23 September 2025
Time: 11:00 a.m.–4:30 p.m
Location: The Chelsea Hotel, 33 Gerrard Street West, Toronto
MDPI is thrilled to announce our participation in the University of Toronto’s largest career fair, taking place at the St. George Downtown Campus. This exciting event brings together thousands of students, graduates, and professionals looking to connect with top employers and explore career opportunities.
We invite all attendees to visit the MDPI booth to discover how you can be part of one of the world’s leading open access academic publishers. Whether you are passionate about scientific research, editorial work, marketing, or supporting global innovation in publishing, we want to meet YOU!
What to expect at our booth:
- Learn more about MDPI’s mission and global impact;
- Explore exciting career opportunities in publishing, editorial, communications, and more;
- Network with our team and ask questions about working at MDPI.
Whether you’re just starting your career or looking to take the next step, don’t miss this opportunity to connect with MDPI. Bring your resume, your curiosity, and your questions—we look forward to seeing you there!
For additional information on the Career Fair and Open MDPI positions, please visit the following links:
1 September 2025
MDPI INSIGHTS: The CEO's Letter #26 - CUJS, Head of Ethics, Open Peer Review, AIS 2025, Reviewer Recognition

Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
Society of China University Journals (CUJS) visit to MDPI Basel
In August, we had the pleasure of welcoming a delegation from the Society of China University Journals (CUJS) to our Basel headquarters. The visit was part of CUJS’s broader European tour, which included meetings with several major publishing organizations.
Purpose of the visit
The delegation’s stop in Basel involved an introductory meeting and knowledge-sharing with a view to identifying potential collaboration opportunities with MDPI. The CUJS team shared an overview of the Chinese scientific publishing landscape, including recent policy developments, and gave us insights into the journals and services they operate across China’s academic institutions.
MDPI presentations
We used the opportunity to introduce CUJS to MDPI’s mission, structure, and recent achievements. I presented on the latest developments at MDPI and our role in supporting global open access, addressing many follow-up questions from the delegation. Warm thanks are due to the following colleagues for their contributions to the session:
- Liliane Auwerter (Conference Organizer, Scientific Officer and Sustainability Specialist) shared an overview of our editorial process, including the quality indicators we use to track peer-review performance.
- Renato Merki (Publication Ethics Assistant) presented on behalf of our Research Integrity and Ethics team, emphasizing our commitment to responsible publishing.
- Silvano Bonfatti (Product Manager) introduced the JAMS platform, highlighting how it supports efficient journal management for editors and publishers alike.
- Aimar Xiong (Publisher, Section Managing Editor) and Giuliano Braccini (Office Manager) facilitated the meeting, offering clarity in response to specific questions, building the relationship during and beyond the meeting itself.
“Building relationships with organizations such as CUJS allows us to increase our visibility and reputation”
Why is this important?
China is one of the world’s largest producers of scientific research, with its universities and research institutes playing a key role in global scholarly publishing. Building strong relationships with influential organizations such as CUJS allows us to increase our visibility and reputation vis-à-vis the Chinese academic community, share best practices, learn from differing publishing models, and explore collaborations that have the potential to enhance the quality, reach, and diversity of our journals.
Looking ahead
It was a productive and friendly exchange that reflected our shared commitment to advancing scholarly communication and improving journal publishing practices. We value these visits, which allow us to create collaborations with stakeholders in the global academic community.
Our Basel office is a hub for hosting international delegations, partners, and collaborators. We look forward to creating more global connections that support our mission.
Impactful Research
Appointment of Dr. Tim Tait-Jamieson as Head of Publication Ethics
As part of our ongoing commitment to research integrity and publishing excellence, I am delighted to announce that we have appointed Dr. Tim Tait-Jamieson as Head of Publication Ethics.
In this role, Tim will lead the development of our ethics strategy and oversee the continued growth of the Publication Ethics Department, which is based across our offices in Basel, Manchester, Belgrade/Novi Sad, and Cluj. Guided by the principles of effective prevention and efficient resolution, the department plays an essential role in ensuring the highest standards of integrity throughout our editorial processes.
Department focus
Working closely with internal teams and external partners, the Publication Ethics Department focuses on refining our policies, aligning our operations with international best practices, and addressing complex cases with fairness and transparency. This work is critical in supporting our editors, reviewers, and authors, reinforcing MDPI’s contribution to the global dialogue on research integrity.
“Research integrity is something to which we all contribute through our daily work at MDPI”
About Tim
Tim joined MDPI in 2021 and has held several roles within the Publication Ethics Department, most recently serving as Research Integrity Lead. Based in our Basel office, he brings a strong academic background, with a Ph.D. in Geography from the University of Fribourg, Switzerland, and a proven track record of leadership in research integrity.
Research integrity is something to which we all contribute through our daily work at MDPI. I look forward to Tim’s leadership as we continue investing in the people, processes, and partnerships that uphold the trust and credibility of scholarly publishing.
Read more:
Inside MDPI
How and why MDPI offers Open Peer Review
At MDPI, we are committed to advancing openness and transparency in scholarly publishing. One area where we’ve taken a leadership role is peer review. Since 2014, MDPI has offered authors the option of open peer review, giving them the opportunity to publish reviewer comments alongside their papers. Each year, more authors are choosing this path, helping to build trust in the editorial process and provide valuable context for the research we publish.
Jack McKenna (Senior Content Specialist, MDPI) recently wrote an informative piece looking at the impact and importance of open peer review at MDPI. He highlights how this approach not only benefits readers but also gives well-deserved recognition to our reviewers, who generously dedicate their time and expertise to the academic community.
I encourage you to read this blogpost to see how MDPI is helping set standards for transparency in scholarly publishing.
Coming Together for Science
Recap of MDPI’s AIS 2025 Conference in Kuala Lumpur
Entering the month of August, we held The 2nd International Conference on AI Sensors and Transducers (AIS 2025) in Kuala Lumpur, Malaysia.
“AIS is quickly becoming a premier event in the field”
The second edition of AIS brought together 335 attendees from across Asia and beyond, including participants from China, Japan, Korea, and Southeast Asia. The event, chaired by Prof. Dr. Toshihiro Itoh (University of Tokyo), Prof. Dr. Sang-Woo Kim (Yonsei University), and Prof. Dr. Chengkuo Lee (National University of Singapore), continues to grow in reputation and has become an important platform for researchers and students to present their work, exchange ideas, and build international collaborations.
AIS is quickly becoming a premier event in the field, with participants highlighting its quality of service, its expanding academic network, and the value it delivers in the context of tightening research budgets in the region.
It was also excellent to see our new MDPI journal AI Sensors, which originated from a conference topic, host a successful launch party at the event.
Highlights from participant feedback:
- Southeast University (China) sent a student delegation and considers AIS a regular fixture for Ph.D. students in need of international conference experience.
- CAS Aerospace Information Research Institute sent a 10-member delegation and plans to further promote AIS internally.
- Japanese researchers regard AIS as a must-attend event, placing it on a par with IEEE conferences and citing the benefits of networking and exchange.
- Korean academics praised the organization and noted improved perceptions of MDPI among their institutions, viewing AIS as a strategic opportunity to deepen engagement in the region.
Award winners
We recognized the recipients of the Best Presentation, Best Scientist, Best Poster, and Best Student Paper awards, whose contributions set a standard for academic excellence. The full award announcement is available here.
Looking ahead
The 3rd International Conference on AI Sensors and Transducers will be held from 5 to10 August 2026 in Jeju, Korea. The General Chairs will be Prof. Inkyu Park (Korea Advanced Institute of Science and Technology), Prof. Zhou Li (Tsinghua University), Prof. Xinge Yu (City University of Hong Kong), and Prof. Chengkuo Lee (National University of Singapore). We look forward to bringing together innovators, researchers and experts who are shaping the future at the intersection of sensors, sensing technology, transducers and artificial intelligence.
Thank you
Our conference team managed this event with great agility and professionalism and are already planning improvements to make the conference even more accessible. Special thanks to the National University of Singapore for their support, and to our entire conference team and collaborators for their dedication.
AIS is gaining momentum, and we look forward to supporting its role as a bridge between MDPI and the global academic community.
“Our conference team managed this event with great agility and professionalism”
Closing Thoughts
Recognizing our outstanding reviewers
As we close this edition of the newsletter, I would like to spotlight MDPI’s 2024 Outstanding Reviewer Awards, which showcase a group of winners whose contributions often go unseen but are essential to the integrity of scholarly publishing: our reviewers.
In 2024, more than 215,000 reviewers dedicated their time and expertise to MDPI journals. From this community, we are proud to recognize 356 recipients of the Outstanding Reviewer Awards, who went above and beyond by providing timely, thorough and constructive feedback.
These awards are not only a token of our appreciation but also a reflection of the values we stand for: rigor, fairness and collaboration in advancing science.
To explore the full list of awardees across disciplines, from life sciences to the humanities, please visit the following pages:
- Biology and Life Sciences
- Business and Economics
- Chemistry and Materials Science
- Computer Science and Mathematics
- Engineering
- Environmental and Earth Sciences
- Medicine and Pharmacology
- Physical Sciences
- Public Health and Healthcare
- Social Sciences, Arts and Humanities
About MDPI Awards
To recognize the academic community, MDPI journals regularly offer various awards to researchers in specific fields. Serving as a source of recognition and inspiration, these awards help increase the influence of scholars who have been credited with outstanding achievements and are making a significant contribution to the advancement of their respective fields.
To explore more opening Outstanding Reviewer Awards, please click here.
To all our reviewers: thank you for being the foundation of trust that makes open access publishing possible!
Chief Executive Officer
MDPI AG